During the past decade, Faculty Hospital; Dialysis Unit conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Faculty Hospital; Dialysis Unit" are "Chronic Renal Anemia" (1 trials) and "Malignant Melanoma" (1 trials). Many other conditions were trialed in "Faculty Hospital; Dialysis Unit" in a lesser frequency.

Most popular intervention types in "Faculty Hospital; Dialysis Unit" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Darbepoetin Alfa" (1 trials), "Epoetin Alfa" (1 trials), "Epoetin Beta" (1 trials), "Vemurafenib" (1 trials) and "methoxy polyethylene glycol-epoetin beta" (1 trials). Other intervention names were less common.

The vast majority of trials in "Faculty Hospital; Dialysis Unit" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Faculty Hospital; Dialysis Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Faculty Hospital; Dialysis Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Faculty Hospital; Dialysis Unit, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".